dsip peptide reconstitution 5mg DSIP 5mg DSIP for Deep Sleep: Benefits,

CagriSema drove an average 13.7% weight loss versus 3.4% for placebo, rising to 15.7% with full adherence

Rizzi C, Tiberi A, Giustizieri M, Marrone MC, Gobbo F, Carucci NM, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 548

Retatrutide Reconstitution Retatrutide - dose per draw at common vial sizes Vial Size 5 mg BAC Water 1.0 mL Concentration 5 mg/mL 2 mg Dose 0.40 mL (40 units) 4 mg Dose 0.80 mL (80 units) 8 mg Dose N/A 12 mg Dose N/A Vial Size 10 mg BAC Water 1.0 mL Concentration 10 mg/mL 2 mg Dose 0.20 mL (20 units) 4 mg Dose 0.40 mL (40 units) 8 mg Dose 0.80 mL (80 units) 12 mg Dose 1.20 mL (120 units*) Vial Size 10 mg BAC Water 2.0 mL Concentration 5 mg/mL 2 mg Dose 0.40 mL (40 units) 4 mg Dose 0.80 mL (80 units) 8 mg Dose 1.60 mL (160 units*) 12 mg Dose 2.40 mL (240 units*) Vial Size 20 mg BAC Water 2.0 mL Concentration 10 mg/mL 2 mg Dose 0.20 mL (20 units) 4 mg Dose 0.40 mL (40 units) 8 mg Dose 0.80 mL (80 units) 12 mg Dose 1.20 mL (120 units*) * Volumes above 100 units exceed a standard 1 mL insulin syringe

Prevention trials targeting preclinical or presymptomatic individuals may yield different results

Its not FDA-approved as a drug, and its not a controlled substance under federal law, which puts it in a gray zone